Standard Chemical & Pharmaceutical Co., Ltd. (TPE:1720)
Taiwan · Delayed Price · Currency is TWD 56.40
-0.20 (-0.35%)
Aug 28, 2026, 1:30 PM CST
TPE:1720 Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 7,080 | 7,023 | 6,789 | 6,240 | 5,851 | 4,604 |
Revenue Growth | 2.85% | 3.44% | 8.81% | 6.64% | 27.09% | 6.94% |
Gross Profit Gross Profit Growth | 3,016 | 2,909 | 2,989 | 2,725 | 2,488 | 2,068 |
Operating Income Operating Income Growth | 1,452 | 1,363 | 1,397 | 1,260 | 1,118 | 876.83 |
Net Income Net Income Growth | 1,027 | 927.66 | 880.5 | 834.89 | 815.41 | 706.73 |
Earnings Per Share EPS Growth | 5.21 | 4.71 | 4.47 | 4.25 | 4.15 | 3.59 |
EPS Growth | 27.63% | 5.29% | 5.35% | 2.41% | 15.45% | 34.81% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Human medicine Human medicine Growth | 3,470 | 3,314 | 3,189 | 2,951 | 2,602 | 2,589 |
Food Food Growth | 2,200 | 2,307 | 2,182 | 2,026 | 2,057 | 1,664 |
Active Pharmaceutical Ingredient Active Pharmaceutical Ingredient Growth | 1,356 | 1,376 | 1,378 | 1,180 | 1,072 | - |
Others Others Growth | 356.55 | 319.65 | 314.2 | 349.74 | 391.23 | 527.56 |
Revenue from internal divisions Revenue from internal divisions Growth | -302.75 | -293.95 | -273.44 | -266.89 | -270.7 | -176.49 |
Total Total Growth | 7,080 | 7,023 | 6,789 | 6,240 | 5,851 | 4,604 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2,322 | 2,385 | 1,804 | 2,268 | 2,480 | 2,757 |
Total Debt Total Debt Growth | 795 | 948.82 | 560.43 | 1,328 | 1,790 | 1,668 |
Net Cash (Debt) Net Cash Growth | 1,527 | 1,436 | 1,244 | 939.65 | 689.98 | 1,089 |
Net Cash Growth | 4.37% | 15.49% | 32.34% | 36.19% | -36.65% | 56.47% |
Net Cash Per Share Net Cash Per Share Growth | 7.76 | 7.30 | 6.32 | 4.78 | 3.51 | 5.53 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,647 | 1,767 | 1,695 | 1,337 | 1,228 | 827.03 |
Capital Expenditures CapEx Growth | -460.33 | -492.87 | -596.48 | -625.7 | -1,196 | -213.48 |
Free Cash Flow Free Cash Flow Growth | 1,187 | 1,274 | 1,098 | 710.83 | 31.78 | 613.56 |
Free Cash Flow Growth | -11.63% | 15.98% | 54.53% | 2136.85% | -94.82% | 7.63% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 42.60% | 41.42% | 44.02% | 43.68% | 42.51% | 44.91% |
Operating Margin | 20.51% | 19.41% | 20.57% | 20.19% | 19.11% | 19.05% |
Pretax Margin | 23.87% | 21.56% | 23.97% | 23.04% | 23.92% | 22.02% |
Profit Margin | 14.51% | 13.21% | 12.97% | 13.38% | 13.94% | 15.35% |
FCF Margin | 16.76% | 18.14% | 16.18% | 11.39% | 0.54% | 13.33% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.818 | 1.818 | 2.546 | 2.454 | 2.273 | 2.273 |
Dividend Per Share Growth | -21.43% | -28.57% | 3.71% | 8.00% | 0% | 38.88% |
Dividend Yield | 3.25% | 3.51% | 4.91% | 4.61% | 4.76% | 7.18% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 10.83 | 11.35 | 12.56 | 14.11 | 13.48 | 10.90 |
Forward PE | - | 11.46 | 12.75 | 11.83 | 11.83 | 14.74 |
P/FCF Ratio | 8.49 | 8.26 | 10.07 | 16.57 | 345.83 | 12.55 |
PS Ratio | 1.42 | 1.50 | 1.63 | 1.89 | 1.88 | 1.67 |